Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for biote Corp. (BTMD : NSDQ)

• Company Description    BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK. Number of Employees: 223

• Price / Volume Information    Yesterday's Closing Price: $1.54 Daily Weekly Monthly 20 Day Moving Average: 345,083 shares Shares Outstanding: 35.93 (millions) Market Capitalization: $55.51 (millions) Beta: 1.60 52 Week High: $3.58 52 Week Low: $1.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.39% 4.92% 12 Week -37.19% -39.53% Year To Date -40.58% -47.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1875 W. WALNUT HILL LN #100 - IRVING,TX 75038 USA ph: 844-604-1246 fax: 888-496-0394 eric.prouty@advisiry.com http://www.biote.com

• General Corporate Information    Officers Bret Christensen - Chief Executive Officer and Director Marc D. Beer - Non-Executive Chairman andChairman of the Board Robert C. Peterson - Chief Financial Officer Richard Barrera - Director Mark Cone - Director Peer Information biote Corp. (BJCT) biote Corp. (CADMQ) biote Corp. (APNO) biote Corp. (UPDC) biote Corp. (IMTIQ) biote Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090683103 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 35.93 Most Recent Split Date: (:1) Beta: 1.60 Market Capitalization: $55.51 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.03 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: 61.80 Trailing 12 Months: 4.54 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 2.66 Price / Sales: 0.30 EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: -9.48% vs. Previous Quarter: -1.56% ROE 06/30/26 - -22.33 03/31/26 - -25.72 12/31/25 - -23.41 ROA 06/30/26 - 12.10 03/31/26 - 15.12 12/31/25 - 14.63 Current Ratio 06/30/26 - 1.43 03/31/26 - 1.29 12/31/25 - 1.22 Quick Ratio 06/30/26 - 0.82 03/31/26 - 0.58 12/31/25 - 0.79 Operating Margin 06/30/26 - 6.75 03/31/26 - 8.29 12/31/25 - 8.51 Net Margin 06/30/26 - 3.19 03/31/26 - 8.29 12/31/25 - 14.07 Pre-Tax Margin 06/30/26 - 5.59 03/31/26 - 12.47 12/31/25 - 19.55 Book Value 06/30/26 - -1.77 03/31/26 - -1.36 12/31/25 - -1.40 Inventory Turnover 06/30/26 - 3.13 03/31/26 - 3.33 12/31/25 - 3.59 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©